Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation
- 1 June 2002
- journal article
- Published by Elsevier BV in Methods
- Vol. 27 (2), 162-169
- https://doi.org/10.1016/s1046-2023(02)00070-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic CellsJNCI Journal of the National Cancer Institute, 2001
- DNA Methylation and Ovarian Cancer: I. Analysis of CpG Island Hypermethylation in Human Ovarian Cancer Using Differential Methylation HybridizationGynecologic Oncology, 2001
- Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor GenesThe American Journal of Pathology, 2001
- DNA methyltransferase expression and DNA methylation of CPG islands and peri‐centromeric satellite regions in human colorectal and stomach cancersInternational Journal of Cancer, 2001
- DNA hypermethylation in tumorigenesis: epigenetics joins geneticsTrends in Genetics, 2000
- CpG island methylator phenotype in colorectal cancerProceedings of the National Academy of Sciences of the United States of America, 1999
- DNA Methylation Differences Associated with Tumor Tissues Identified by Genome Scanning AnalysisGenomics, 1998
- Establishment of methylation-sensitive–representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumorsProceedings of the National Academy of Sciences of the United States of America, 1997
- Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Increased Cytosine DNA-Methyltransferase Activity During Colon Cancer ProgressionJNCI Journal of the National Cancer Institute, 1993